195 related articles for article (PubMed ID: 33948301)
1. Preliminary clinical outcomes of patients treated with vaginal brachytherapy alone using multi-channel vaginal brachytherapy applicator in operated early-stage endometrial cancer.
Rishi KS; David S; Pathikonda M; Ramachandra P; Giri GV; Vadaparty A; Srinath BS
Rep Pract Oncol Radiother; 2021; 26(1):43-49. PubMed ID: 33948301
[TBL] [Abstract][Full Text] [Related]
2. Design and Development of In-House Multichannel Applicator for HDR Vaginal Brachytherapy and Dosimetric Comparision with Single Channel Applicator.
Govindaraj K; Shanmugam S; Sampathrajan S
Asian Pac J Cancer Prev; 2019 Dec; 20(12):3805-3810. PubMed ID: 31870125
[TBL] [Abstract][Full Text] [Related]
3. Single versus multichannel applicator in high-dose-rate vaginal brachytherapy optimized by inverse treatment planning.
Bahadur YA; Constantinescu C; Hassouna AH; Eltaher MM; Ghassal NM; Awad NA
J Contemp Brachytherapy; 2015 Jan; 6(4):362-70. PubMed ID: 25834580
[TBL] [Abstract][Full Text] [Related]
4. Low-dose adjuvant vaginal cylinder brachytherapy for early-stage non-endometrioid endometrial cancer: recurrence risk and survival outcomes.
Smart A; Buscariollo D; Alban G; Buzurovic I; Cheng T; Pretz J; Krechmer B; King M; Lee L
Int J Gynecol Cancer; 2020 Dec; 30(12):1908-1914. PubMed ID: 32655012
[TBL] [Abstract][Full Text] [Related]
5. Do vaginal recurrence rates differ among adjuvant vaginal brachytherapy regimens in early-stage endometrial cancer?
Ager BJ; Francis SR; Do OA; Huang YJ; Soisson AP; Dodson MK; Werner TL; Sause WT; Grant JD; Gaffney DK
Brachytherapy; 2019; 18(4):453-461. PubMed ID: 31005603
[TBL] [Abstract][Full Text] [Related]
6. Vaginal brachytherapy alone: an alternative to adjuvant whole pelvis radiation for early stage endometrial cancer.
Jolly S; Vargas C; Kumar T; Weiner S; Brabbins D; Chen P; Floyd W; Martinez AA
Gynecol Oncol; 2005 Jun; 97(3):887-92. PubMed ID: 15943991
[TBL] [Abstract][Full Text] [Related]
7. American Brachytherapy Society survey regarding practice patterns of postoperative irradiation for endometrial cancer: current status of vaginal brachytherapy.
Small W; Erickson B; Kwakwa F
Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1502-7. PubMed ID: 16109462
[TBL] [Abstract][Full Text] [Related]
8. Vaginal vault brachytherapy as sole postoperative treatment for low-risk endometrial cancer.
Chong I; Hoskin PJ
Brachytherapy; 2008; 7(2):195-9. PubMed ID: 18358790
[TBL] [Abstract][Full Text] [Related]
9. External beam radiotherapy versus vaginal brachytherapy in patients with stage II endometrial cancer: a systematic review and meta-analysis.
Narasimhulu DM; Cope A; Riaz IB; Petersen I; Cilby W; Langstraat C; Glaser G; Kumar A; Cappuccio S; Murad MH; West C; Mariani A
Int J Gynecol Cancer; 2020 Jun; 30(6):797-805. PubMed ID: 32221021
[TBL] [Abstract][Full Text] [Related]
10. A novel low dose fractionation regimen for adjuvant vaginal brachytherapy in early stage endometrioid endometrial cancer.
Townamchai K; Lee L; Viswanathan AN
Gynecol Oncol; 2012 Nov; 127(2):351-5. PubMed ID: 22850411
[TBL] [Abstract][Full Text] [Related]
11. Postoperative vaginal brachytherapy alone is the treatment of choice for grade 1-2, stage IC endometrial cancer.
Cengiz M; Singh AK; Grigsby PW
Int J Gynecol Cancer; 2005; 15(5):926-31. PubMed ID: 16174247
[TBL] [Abstract][Full Text] [Related]
12. EROS 2.0 study: evaluation of two interventional radiotherapy (brachytherapy) schedules for endometrial cancer: a comparison of late vaginal toxicity rates.
Lancellotta V; Macchia G; Dinapoli N; Autorino R; Campitelli M; Nardangeli A; Salvati A; Fionda B; Casà C; Cornacchione P; Rovirosa A; Kovács G; Morganti AG; Ferrandina MG; Gambacorta MA; Tagliaferri L
Radiol Med; 2022 Mar; 127(3):341-348. PubMed ID: 35092552
[TBL] [Abstract][Full Text] [Related]
13. Postoperative brachytherapy for endometrial cancer using a ring applicator.
Vanneste BG; Meijnen P; Hammerstein CS; Bijker N; van Os RM; Stalpers LJ; Pieters BR
Brachytherapy; 2015; 14(2):273-8. PubMed ID: 25456027
[TBL] [Abstract][Full Text] [Related]
14. Patterns of failure in endometrial carcinoma stage IB grade 3 and IC patients treated with postoperative vaginal vault brachytherapy.
Chadha M; Nanavati PJ; Liu P; Fanning J; Jacobs A
Gynecol Oncol; 1999 Oct; 75(1):103-7. PubMed ID: 10502434
[TBL] [Abstract][Full Text] [Related]
15. Definitive salvage for vaginal recurrence of endometrial cancer: the impact of modern intensity-modulated-radiotherapy with image-based HDR brachytherapy and the interplay of the PORTEC 1 risk stratification.
Vargo JA; Kim H; Houser CJ; Berhane H; Sukumvanich P; Olawaiye AB; Kelley JL; Edwards RP; Comerci JT; Huang M; Courtney-Brooks M; Beriwal S
Radiother Oncol; 2014 Oct; 113(1):126-31. PubMed ID: 25241996
[TBL] [Abstract][Full Text] [Related]
16. Image-based multichannel vaginal cylinder brachytherapy for vaginal cancer.
Vargo JA; Kim H; Houser CJ; Sukumvanich P; Olawaiye AB; Kelley JL; Edwards RP; Comerci JT; Huang M; Courtney-Brooks M; Beriwal S
Brachytherapy; 2015; 14(1):9-15. PubMed ID: 25456026
[TBL] [Abstract][Full Text] [Related]
17. Adjuvant brachytherapy for FIGO stage I serous or clear cell endometrial cancer.
Jeans EB; Breen WG; Mullikin TC; Looker BA; Mariani A; Keeney GL; Haddock MG; Petersen IA
Int J Gynecol Cancer; 2021 Jun; 31(6):859-867. PubMed ID: 33563642
[TBL] [Abstract][Full Text] [Related]
18. Recurrences and toxicity after adjuvant vaginal brachytherapy in Stage I-II endometrial cancer: A monoinstitutional experience.
Perrucci E; Lancellotta V; Bini V; Zucchetti C; Mariucci C; Montesi G; Saccia S; Palumbo I; Aristei C
Brachytherapy; 2016; 15(2):177-84. PubMed ID: 26727332
[TBL] [Abstract][Full Text] [Related]
19. Image-based multichannel vaginal cylinder brachytherapy for the definitive treatment of gynecologic malignancies in the vagina.
Gebhardt BJ; Vargo JA; Kim H; Houser CJ; Glaser SM; Sukumvanich P; Olawaiye AB; Kelley JL; Edwards RP; Comerci JT; Courtney-Brooks M; Beriwal S
Gynecol Oncol; 2018 Aug; 150(2):293-299. PubMed ID: 29929925
[TBL] [Abstract][Full Text] [Related]
20. Intravaginal brachytherapy alone for intermediate-risk endometrial cancer.
Alektiar KM; Venkatraman E; Chi DS; Barakat RR
Int J Radiat Oncol Biol Phys; 2005 May; 62(1):111-7. PubMed ID: 15850910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]